March 7 – 8, 2022
2022 ESMO Targeted Anticancer Congress, Virtual
AUM Biosciences, Handok Inc. [002390: KOSPI] (“Handok”), and CMG Pharmaceutical Co. Ltd. [058820: KOSDAQ] (“CMG”) will conduct a poster presentation on Phase 1 data for AUM-601 (CHC2014), a selective second generation “Pan-TRK” Inhibitor, at the ESMO Targeted Anticancer Congress 2022. The poster is titled, “A first-in-human, open-label, dose-escalation study to investigate the safety and tolerability of CHC2014, a tropomyosin receptor kinase (TRK) inhibitor, in adult patients with advanced solid tumors” and the lead author and presenter will be Tak Yun, MD, PhD.
February 14 – 17, 2022
2022 ChinaBio® Partnering Forum, Beijing, China & Virtual
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, will be attending and accepting one-on-one meetings at the Bio CEO & Investor Conference in New York, NY. For more than 20 years, the BIO CEO & Investor Conference has fuelled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
November 18, 2021
Bio Connections Australia 2021, Melbourne
Panel participation by Dr. John Patava, Chief Operating Officer, AUM Biosciences, answers the different ways Australia can become a global clinical trials player hosted by Informa.
August 25, 2021
PI3K Pathways Virtual Summit 2021, Massachusetts
Dr. Harish Dave, Co-Founder and CMO, AUM Biosciences will present promising combination therapies involving co-targeting PIM Kinase and PI3K/mTOR at this summit.
May 27, 2021
IQVIA Biotech Industry Opportunities Conference
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, to present a brief about AUM Biosciences’ portfolio of oncological medicines hosted by IQVIA Biotech.
April 27, 2021
UBS Healthcare Summit 2021
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, to present an overview of the company’s next-generation therapies at the Summer Private Company Showcase 2021.
August 10, 2020
Summer Private Company Showcase 2020
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, will be presenting an overview of the company at the Summer Private Company Showcase 2020 hosted by Solebury Trout, Piper Sandler and White & Case.
June 12, 2020
Capital 2020 Virtual Investor Conference
AUM Biosciences will be presenting its oncology pipeline at the Capital 2020 Virtual Investor Conference. This event brings together companies from a range of sectors including healthcare, AI and deep technologies, and many more.
February 6, 2020
Therapeutic Investability: Who Shall Be Invited to Dance?
Panel participation by Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, to review the life science investment landscape in Asia, hosted by SGInnovate and Eureka Institute for Translational Medicine.
February 19 – 20, 2020
13th Annual European Life Sciences CEO Forum 2020, Switzerland
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, will be attending and speaking at the 13th Annual European Life Sciences CEO Forum for Partnering & Investment in Zurich, Switzerland.
Aug 19 – 20, 2019
Bio Connections Australia 2019
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, will speak about “Asia to Global Strategy for Success” as a keynote speaker at Bio Connections Australia, an annual national event designed to foster the growth of early phase clinical research in Australia.
June 26, 2019
Official Opening Of EDDC, Singapore
AUM Biosciences will be a part of the official opening of the Experimental Drug Development Centre (EDDC) at the Matrix Auditorium. The Guest-of-Honour for this event will be Mr. Heng Swee Keat, Minister for Finance and Chairman of the National Research Foundation (NRF).
June 3 – 6, 2019
BIO International Convention 2019, Philadelphia
AUM Biosciences will attend Biotechnology Innovation Organization (BIO) International Convention 2019, Philadelphia. It represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
May 31 – June 4, 2019
ASCO Annual Meeting 2019, Chicago
AUM Biosciences will be at ASCO (American Society of Clinical Oncology) – 2019, a robust program designed to teach, engage, and bring the oncology field together, in Chicago.
May 14, 2019
AUM Biosciences and GLG organise a panel discussion in 2019, Singapore
Panel participation by Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, to discuss the various emerging business models in drug development and to exchange views about the risks and opportunities involved in the future of drug development, organized by AUM Biosciences and GLG.
April 17 – 19, 2019
Bio Korea 2019 International Convention, Seoul
AUM Biosciences will be presenting at the 14th Bio Korea 2019 International Convention, where the international information exchange and technology transfer of Korea’s biotech industry takes place.
March 18 – 20, 2019
Phar-East 2019 Conference, Singapore
AUM Biosciences will be presenting at the Phar-East 2019 Conference, which is part of Asia’s Pharma and Biotech festival, a premier meeting for key opinion leaders from Asia’s pharma and biotech industry.
February 25 – 27, 2019
BIO Asia International Conference 2019, Hyderabad
AUM Biosciences will be presenting at the BIO Asia International Conference to be held in Hyderabad, India.
February 11 – 12, 2019
BIO CEO & Investor Conference 2019, New York
AUM Biosciences will be presenting at the BIO CEO & Investor Conference, one of the largest biotech investor conferences to be held in New York.
January 7 – 10, 2019
J.P. Morgan 37th Annual Healthcare Conference 2019, San Francisco
AUM Biosciences has been invited to attend the J. P Morgan 37th Annual Healthcare Conference. It is one of the largest and most informative healthcare investment symposiums in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and investment community members worldwide.
January 6, 2019
China Focus@JPM Week event 2019, San Francisco
AUM has been invited to attend the China Focus@JPM Week event that brings together investors and pharma leaders from China and healthcare innovators to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world.
December 1 – 4, 2018
60th American Society of Hematology (ASH) Annual Meeting and Exposition 2018, San Diego
AUM Biosciences is excited to participate in invaluable educational exchanges and vibrant discussions on the hottest topics in Hematology at the 60th American Society of Hematology (ASH) annual meeting and exposition–touted as the “world’s most comprehensive Hematology event of the year”.
November 5 – 7, 2018
24th Annual International Partnering Conference, Bio-Europe 2018, Copenhagen, Denmark
AUM Biosciences attended the 24th Annual International Partnering Conference, Bio-Europe– Europe’s largest life science partnering conference offering world-class workshops, panels and active exhibitions along with thousands of prescheduled one-to-one meetings making this event an unrivalled forum for companies across the biotech value chain to meet and do business.
October 31 – November 2, 2018
Biotech Investment Summit 2018, Singapore
Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, will speak about ‘Understanding the burgeoning Asian Oncology market’ at the Biotech Investment Summit. Vishal was also invited to participate in a Panel Discussion at the Biopharma Development and Production 2018 Closing Plenary Session.
October 22 – 23, 2018
US-China Biopharma Innovation & Investment Summit 2018, Shanghai
AUM Biosciences attended the 2-day US-China Biopharma Innovation & Investment Summit– the conference brings together movers and shakers in the emerging healthcare markets with a forecast on drug innovation and a special focus on the regulatory scene.
September 18 – 21, 2018
Digital Pharma Summit 2018, Singapore
Panel participation by Vishal Doshi, Chairman & Chief Executive Officer, AUM Biosciences, to discuss various themes in Digital Transformation in the Asian context.
September 18 – 21, 2018
2nd Annual Accelerating Clinical Trials in Asia Conference 2018, Singapore
AUM Biosciences Co-Founder and CMO Harish Dave will present at the 2nd Annual Accelerating Clinical Trials Asia Conference on Moving Beyond Oncology: A small molecular strategy.
July 18 – 19, 2018
8th Annual AVCJ Forum 2018, Singapore
AUM Biosciences will be attending the 8th Annual AVCJ Forum in Singapore, the premier private equity & venture forum in Southeast Asia.
July 9 – 12, 2018
RISE conference 2018, Hong Kong
AUM Biosciences was amongst 70 out of 700 start-ups to be shortlisted as a candidate for PITCH at RISE, held in Hong Kong on 9-12 July 2018. The conference brought together major global media, hundreds of investors and over 15,000 attendees.
June 1 – 5, 2018
ASCO, 1-5 June, Chicago
AUM Biosciences will be attending the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
May 18, 2018
C-CAMP Development Workshop 2018, Bangalore
AUM Biosciences will be attending the C-CAMP Development Workshop in Bangalore, India.